NOTCH3 Human Pre-designed siRNA Set A contains three designed siRNAs for NOTCH3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOTCH4 Human Pre-designed siRNA Set A contains three designed siRNAs for NOTCH4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOTO Human Pre-designed siRNA Set A contains three designed siRNAs for NOTO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOTPis a bifunctional chelator (Bifunctional Chelator; BFC) and a macrocyclic NOTA derivative used for tumor pre-targeting. NOTP can be used for conjugation of peptides and radionuclides.

NOTUM Human Pre-designed siRNA Set A contains three designed siRNAs for NOTUM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOVA1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOVA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOVA2 Human Pre-designed siRNA Set A contains three designed siRNAs for NOVA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Novaluron (Standard) is the analytical standard of Novaluron. This product is intended for research and analytical applications.

NOX1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nox1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nox1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nox1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nox1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOX2-IN-3 (compound 3) is an inhibitor of NOX2 (NADPH Oxidase 2). NOX2-IN-3 sensitizes tumor cells to MRTX1133 (HY-134813)[1].

NOX3 Human Pre-designed siRNA Set A contains three designed siRNAs for NOX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOX4 Human Pre-designed siRNA Set A contains three designed siRNAs for NOX4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nox4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nox4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nox4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nox4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOX5 Human Pre-designed siRNA Set A contains three designed siRNAs for NOX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOXA1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOXA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NOXO1 Human Pre-designed siRNA Set A contains three designed siRNAs for NOXO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NP-BTA is an allosteric inhibitor for glutaminyl-tRNA synthetase (GlnRS). NP-BTA exhibits antifungal efficacy against Candida albicans, with MIC50 of 6.25 μM[1].

NPAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPAS1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPAS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPAS2 Human Pre-designed siRNA Set A contains three designed siRNAs for NPAS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPAS3 Human Pre-designed siRNA Set A contains three designed siRNAs for NPAS3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPAS4 Human Pre-designed siRNA Set A contains three designed siRNAs for NPAS4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPAT Human Pre-designed siRNA Set A contains three designed siRNAs for NPAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPB Human Pre-designed siRNA Set A contains three designed siRNAs for NPB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPC1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPC1L1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPC1L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPC2 Human Pre-designed siRNA Set A contains three designed siRNAs for NPC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPEPL1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPEPL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPEPPS Human Pre-designed siRNA Set A contains three designed siRNAs for NPEPPS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPFF Human Pre-designed siRNA Set A contains three designed siRNAs for NPFF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPFF1-R antagonist 1 (compound 8b), a piperidine analogue, is a potent neuropeptide FF (NPFF) receptor antagonist. NPFF1-R antagonist 1 is 15-fold selective for the NPFF1-R subtype, with Ki values of 211 nM and 3270 nM for NPFF1-R and NPFF2-R, respectively[1].

NPFF2-R ligand 1 (Compound 16a) is a NPFF2-R ligand, with Kis of 228 and 27 nM for NPFF1-R and NPFF2-R respectively. NPFF2-R ligand 1 can be used for research related with central nervous system[1].

NPFFR1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPFFR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPFFR2 Human Pre-designed siRNA Set A contains three designed siRNAs for NPFFR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPHP1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPHP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPHP3 Human Pre-designed siRNA Set A contains three designed siRNAs for NPHP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPHP4 Human Pre-designed siRNA Set A contains three designed siRNAs for NPHP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPHS1 Human Pre-designed siRNA Set A contains three designed siRNAs for NPHS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nphs1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nphs1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPHS2 Human Pre-designed siRNA Set A contains three designed siRNAs for NPHS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NPI52 (Compound E1) is a foot-and-mouth disease virus 3C protease (FMDV 3Cpro) inhibitor, with IC50 values of 0.05 and 0.11 µM in FRET and cell-based assay, respectively[1].